Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

NCT01802593 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

20

Enrollment

OTHER_GOV

Sponsor class

Stopped lack of budget and failure to reach milestones

Conditions

Crohn's Disease

Interventions

DRUG: AZATHIOPRINE or METHOTREXATE
DRUG: AZATHIOPRINE or METHOTREXATE

Sponsor

Prof. Arie Levine